![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://static.elsevier.es/multimedia/00017310/0000011500000001/v1_202401030514/S0001731023008505/v1_202401030514/en/main.assets/fx1.jpeg)
glp 1 and psoriasis
Shipping Estimate
glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held
USD24.87
USD49.87
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1984462958858456)
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://cdn.sanity.io/images/0vv8moc6/hcplive/e2fd60a98d4330184349bd299293208bf60a37db-300x300.jpg)
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://assets.medpagetoday.net/media/images/121xxx/121299.jpg?width=0.8)
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=10165533791913735)
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://ars.els-cdn.com/content/image/1-s2.0-S2352512626000810-gr1.jpg)
![glp 1 and psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases For years, conventional wisdom held](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41584-025-01302-0/MediaObjects/41584_2025_1302_Fig2_HTML.png)
